scholarly journals Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial

2019 ◽  
Vol 21 (8) ◽  
pp. 1967-1972 ◽  
Author(s):  
Melanie J. Davies ◽  
David Russell‐Jones ◽  
Thomas M. Barber ◽  
Fernando J. Lavalle‐González ◽  
Gagik R. Galstyan ◽  
...  
2009 ◽  
Vol 28 (5) ◽  
pp. 549-555 ◽  
Author(s):  
Nachum Vaisman ◽  
Mirian Lansink ◽  
Carlette H. Rouws ◽  
Katrien M. van Laere ◽  
R. Segal ◽  
...  

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Àngels Molló ◽  
Anna Berenguera ◽  
Esther Rubinat ◽  
Bogdan Vlacho ◽  
Manel Mata ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document